Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership455,870 shares
Latest Disclosed Value $ 238,681,931
Geode Capital Management, Llc reports 0.91% increase in ownership of YDO1 / Madrigal Pharmaceuticals, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 455,870 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $205,278,261 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 451,743 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 0.91% during the quarter. The current value of the position is $194,291,794 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 455,870 4,127 0.91 238,682 -9.29 0.0079
2026-02-09 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 451,743 5,510 1.23 263,114 28.54 0.0162
2025-11-12 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 446,233 31,841 7.68 204,701 63.20 0.0131
2025-08-08 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 414,392 -6,483 -1.54 125,428 -10.05 0.0088
2025-05-13 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 420,875 10,297 2.51 139,437 10.04 0.0110
2025-02-12 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 410,578 4,923 1.21 126,719 47.17 0.0098
2024-11-12 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 405,655 5,801 1.45 86,104 -23.15 0.0070
2024-08-09 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 399,854 52,997 15.28 112,045 20.95 0.0098
2024-05-13 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 346,857 10,602 3.15 92,638 19.06 0.0086
2024-02-13 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 336,255 39,817 13.43 77,812 79.71 0.0081
2023-11-13 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 296,438 25,119 9.26 43,297 -30.92 0.0052
2023-08-11 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 271,319 23,262 9.38 62,675 4.29 0.0074
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 248,057 11,472 4.85 60,094 88,273.53 0.0078
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 236,585 6,799 2.96 69 -99.54 0.0096
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 229,786 4,984 2.22 14,933 -7.20 0.0023
2022-08-12 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 224,802 6,814 3.13 16,091 -24.77 0.0024
2022-05-13 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 217,988 -2,030 -0.92 21,388 14.72 0.0027
2022-02-11 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 220,018 17,643 8.72 18,644 15.46 0.0022
2021-11-12 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 202,375 4,271 2.16 16,147 -16.32 0.0022
2021-08-13 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 198,104 43,308 27.98 19,297 6.58 0.0027
2021-05-12 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 154,796 12,790 9.01 18,106 14.70 0.0028
2021-02-12 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 142,006 3,980 2.88 15,786 -3.67 0.0026
2020-11-13 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 138,026 -764 -0.55 16,387 4.26 0.0032
2020-08-13 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 138,790 -130 -0.09 15,717 69.47 0.0034
2020-05-14 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 138,920 14,987 12.09 9,274 -17.86 0.0024
2020-02-20 2019-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 123,933 12,032 10.75 11,291 17.03 0.0024
2020-02-13 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 123,933 12,032 11,291 1,438.9389
2019-11-12 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 111,901 2,433 2.22 9,648 -15.91 0.0023
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 109,468 9,895 9.94 11,473 -8.01 0.0028
2019-05-14 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 99,573 9,057 10.01 12,472 22.25 0.0032
2019-03-06 2018-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 90,516 4,536 5.28 10,202 -44.58 0.0032
2019-02-13 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 90,516 4,536 10,202
2018-11-13 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 85,980 5,964 7.45 18,410 -17.74 0.0052
2018-08-14 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 80,016 28,514 55.36 22,379 272.12 0.0069
2018-05-15 2018-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 51,502 -2,797 -5.15 6,014 20.67 0.0020
2018-02-13 2017-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 54,299 18,319 50.91 4,984 208.03 0.0017
2017-11-14 2017-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 35,980 3,740 11.60 1,618 208.78 0.0006
2017-08-14 2017-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 32,240 6,419 24.86 524 31.99 0.0002
2017-06-21 2017-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 25,821 216 0.84 397 4.20 0.0002
2017-05-12 2017-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 25,821 397
2017-02-14 2016-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 25,605 7,288 39.79 381 64.22 0.0002
2016-11-10 2016-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 18,317 18,317 232 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.